Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007358 · ClinicalTrials.gov registry record · NA
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00007358 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants.
The verdict
NCT00007358, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Some newborns are born with congenital heart block (CHB), a condition occurring in babies with neonatal lupus. The first part of the study will test the effectiveness of fluorinated steroids, including dexamethasone, in improving the heart function and general health of newborns who have auto-antibody-associated CHB. The second part of this study will use ultrasound and heart monitoring to observe high-risk pregnant women and their fetuses during the third trimester of pregnancy.
Interventions
- DRUG Dexamethasone or other corticosteroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-10 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007358
The ClinicalTrials.gov registry entry for NCT00007358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone or other corticosteroid is the first listed.
NCT00007358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007358 about?
NCT00007358 is a clinical study titled "Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus". Some newborns are born with congenital heart block (CHB), a condition occurring in babies with neonatal lupus. The first part of the study will test the effectiveness of fluorinated steroids, including dexamethasone, in improving the heart function and general health of newborns who have auto-antibo...
What is the current status of trial NCT00007358?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2000-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00007358?
The interventions under investigation include: Dexamethasone or other corticosteroid (DRUG).
Who is sponsoring clinical trial NCT00007358?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.